Fig. 3From: A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumorsMedian distribution of CD3+ T cells of all patients. Abbreviations: CD, Cluster of differentiation; appl, applicationBack to article page